Home » Newsletters » BioWorld Science

BioWorld Science

June 22, 2000

View Archived Issues

ImClone Systems and Princeton launch genomics program

Safety of oral sildenafil demonstrated in men with heart disease

Studies reveal long-term benefits of two different Crohn's disease treatments

Preclinical studies suggest role for relaxin in treating vascular insufficiency

Lorus Therapeutics allowed U.S. patent for GTI-2501

Novartis and Modex to research encapsulated protein delivery in cancer therapy

Cancer drug resistance may be inhibited by drug for alcoholism

Licensing opportunity from NIH: gene therapy technique for heart disease

Licensing opportunity from NIH: polypeptides interacting with formyl peptide receptors

Active Biotech updates Q1 progress

Antiallergic agents from JT inhibit the production of IgE and IL-5

Toyama describes AP-1 inhibitors; exemplified compound effective in mouse arthritis model

Halimide: a new cytotoxic alkaloid discovered at the University of California

Potent antifungal agents in the Meiji Seika pipeline

GH secretagogues and their use described by Pfizer

Carbapenems from Banyu useful as antibacterials and beta-lactamase inhibitors

First drug to reverse effects of Fabry's disease developed at U. of Michigan

Mylotarg now available in U.S. as treatment for relapsed AML

NCX-1015 proves superior to prednisolone as regards both antiinflammatory efficacy and safety

FDA grants approval to Novo Nordisk's liquid Norditropin

Potent inhibition of bone resorption demonstrated for the NO-NSAID HCT-1026

Exelon now available in U.S. for treatment of Alzheimer's

TP receptor antagonist S-18886 shows broad-spectrum antiplatelet effects

Myocardial protective effects described for Bay-x-1005 at recent international conference

Extensive pharmacological characterization of NN-2211 reported at recent diabetes meeting

Stockholder meeting for proposed three-way merger scheduled for July 31

New guanidino distamycin analogue selected by Pharmacia for clinical development

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...